WW Q1 revenue down 9.7% to $186.6M; clinical revenue up 57%; in debt restructuring talks

WW INTERNATIONAL, INC.

2025-Q1 EPS reported -$0.91 vs consensus -$0.31 ▼ miss (-194.5%)

Net loss improved to $72.6M ($0.91 EPS loss) from $347.9M ($4.39) YoY.
Clinical subscription revenue rose 57.1% to $29.5M; total subscribers fell 14.2% to 3.4M.
Adjusted EBITDAS surged to $26.9M from $7.2M; gross margin expanded 450 bps to 71.2%.
Substantive discussions with lenders/noteholders on debt-reduction plan expected imminently.
Cash and equivalents $236.3M including $171.3M drawn on revolver.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.